期刊文献+

2型糖尿病心血管自主神经病变患者P-选择素水平分析

P-selectin level in type 2 diabetes mellitus patients complicated with cardiovascular autonomic neuropathy
原文传递
导出
摘要 目的探讨2型糖尿病心血管自主神经病变与P-选择素的关系。方法采用ELISA法检测42例体检健康者(对照组),45例2型糖尿病患者(单纯糖尿病组)及51例2型糖尿病合并心血管自主神经病变患者(合并组)血浆可溶性P-选择素水平。结果合并组、单纯糖尿病组和对照组血浆可溶性P-选择素分别为(56.1±5.2)、(33.5±7.8)、(18.7±6.3)μg/L,3组比较差异均有统计学意义(P<0.01);多元逐步回归分析显示,糖化血红蛋白、三酰甘油是可溶性P-选择素的独立影响因素。结论 P-选择素可能与2型糖尿病心血管自主神经病变的发生有关。 Objective To investigate the association between soluble P-selectin and cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus (T2DM). Methods The plasma level of soluble P-selectin was measured in 42 normal subjects (control group), 45 T2DM patients (T2DM group) and 51 T2DM patients complicated with cardiovascular autonomic neuropathy (DCAN group) by ELISA technique. Results The plasma levels of soluble P-selectinwere (56.1±5. 2), (33. 5±7.8) and (18. 7±6. 3) μg/L in DCAN, T2DM and control groups, showing significant differences among three groups (P 〈 0.01). Multiple stepwise regression analysis showed glycosylated hemoglobin Alc and triacylglycerol were independent risk factors for soluble P-selectin level. Conclusion P-selectin might be involved in the development of cardiovascular autonomic neuropathy in T2DM patients.
出处 《中华实用诊断与治疗杂志》 2014年第9期874-875,878,共3页 Journal of Chinese Practical Diagnosis and Therapy
基金 河南省医学科技攻关计划项目(2011020139)
关键词 2型糖尿病 心血管自主神经病变 P-选择素 Type 2 diabetes mellitus cardiovascular autonomic neuropathy P-selectin
  • 相关文献

参考文献10

  • 1Vinik AI, Erbas T. Diabetic autonomic neuropathy[J]. Handb Clin Neurol, 2013,117: 279-294.
  • 2Stranieri A, Abawajy J, Kelarev A, et al. An approach for Ewing test selection to support the clinical assessment of cardiac autonomic neuropathy[J]. Artif Intell Med,2013,58(3):185- 193.
  • 3Tang M, Donaghue KC, Cho YH, etal. Autonomic neuropathy in young people with type 1 diabetes: a systematic review[J]. Pediatr Diabetes, 2013,14(4) :239-248.
  • 4Adler GK, Bonyhay I, Failing H, et al. Antecedent hypoglycemia impairs autonomic cardiovascular function:implications for rigorous glycemic control[J]. Diabetes,2009,58 (2) :360-366.
  • 5Kitsios K, Tsapas A, Karagianni P. Glycemia and cardiovascular risk: challenging evidence based medicine[J]. Hippokratia, 2011,15(3) : 199-204.
  • 6Rauch U, Ziegler D, Piolot R, et al. Platelet activation in diabetic cardiovascular autonomic neuropathy[J]. Diabet Med, 1999,16(10) :848-852.
  • 7Vinik AI, Erbas T, Casellini CM. Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease [J]. J Diabetes Investig,2013,4(1) :4-18.
  • 8胡晓莉,孙侃.氧化应激与糖尿病神经病变相关性研究[J].中华实用诊断与治疗杂志,2011,25(4):318-320. 被引量:28
  • 9Serebruany VL, Miller M, Pokov AN, et al. Early impact of prescription Omega-3 fatty acids on platelet biomarkers in patients with coronary artery disease and hypertriglyceridemia [J]. Cardiology,2011,118(3) :187-194.
  • 10Woollard KJ, Chin-Dusting J. P-selectin antagonism in inflammatory disease[J]. Curr Pharm Des,2010,16(37) :4113- 4118.

二级参考文献25

  • 1LiF, Drel V R, Szabo C, et al. Low dose poly(ADP-ribose) polymerase inhibitor containing combination therapies reverse early peripheral diabetic neuropathy[J]. Diabetes, 2005,54 (5) : 1514-1522.
  • 2Gruden G, Bruno G, Chaturvedi N, et al. Serum heat shock protein 27 and diabetes complications in the EURODIAB prospective complications study: a novel circulating marker for diabetic neuropathy[J]. Diabetes,2008,57(7) : 1966-1970.
  • 3Kellogg A P, Pop-Busui R. Peripheral nerve dystunction in experimental diabetes is mediated by cyclooxygenase 2 and oxidative stress[J]. Antioxid Redox Signal, 2005,7(11-12):1521-1529.
  • 4Little A A, Edwards J L, Feldman E L. Diabetic neuropathies [J]. Pract Neurol,2007,7(2):82-92.
  • 5Maritim A C, Sanders R A, Watkins J B. Diabetes, oxidative stress, and antioxidants: a review[J]. J Biochem Mol Toxicol, 2003,17(1):24-38.
  • 6Davi G, Ciabattoni G, Consoli A, et al. In vivo formation of 8-iso prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation[J]. Coirculation,1999,99(2):224-229.
  • 7Pop Busui R, Kirkwood I, Schmid H, et al. Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and diastolic dysfunction[J]. J Am Coll Cardiol,2004,44(12) :2368-2374.
  • 8Obrosova I G, Drel V R, Oltman C L, et al. Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocindiabetic rats[J]. Am J Physiol, 2007,293(6): E1645-1655.
  • 9Leinninger G M, Backus C, Sastry A M, et al. Mitochondria in DRG neurons undergo hyperglycemic mediated injury through Bim, Bax and the fission protein Drpl[J]. Neurobiol Dis, 2006, 23(1):11-22.
  • 10Arnoult D, Rismanchi N, Grodet A, et al. Bax/Bak dependent release of DDP/TIMM8a promotes Drpl mediated mitochondrial fission and mitoptosis during programmed cell death[J]. Curr Biol,2005,15(23):2112-2118.

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部